Gorlin Syndrome, Vulvar Basal Cell Carcinomas, Vismodegib, and Lichen Sclerosus: From the ISSVD Case Consultation Committee.
1Maternity and Gynaecology, John Hunter Hospital, New Lambton, New South Wales; 2Obstetrician and Gynaecologist, East Melbourne, Victoria; and 3Anatomical Pathology, Pathology North, Hunter New England, New Lambton, New South Wales; and Faculty of Medicine and Health, University of Newcastle, Callaghan, New South Wales, Australia.
Emily
E
Kirkpatrick
Dwina
D
Dobriansky
James
J
Scurry
D000368:Aged; D000813:Anilides / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001478:Basal Cell Nevus Syndrome / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D002280:Basal Cell Carcinoma / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D005260:Female; D006651:Histocytochemistry; D006801:Humans; D018459:Lichen Sclerosus et Atrophicus / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D008853:Microscopy; D011725:Pyridines / Q000627:therapeutic use*; D016896:Treatment Outcome; D014845:Vulvar Diseases / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy
D000813:Anilides; D000970:Antineoplastic Agents; C538724:HhAntag691; D011725:Pyridines